Skip to content

EFFICACY OF USUAL MANAGEMENT BY LOCAL ANESTHETIC INFILTRATION IN THE TREATMENT OF CHRONIC IDIOPATHIC ANO-PERINEAL PAIN: A RANDOMIZED DOUBLE-BLIND -CONTROLLED TRIAL

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518148-19-00
Acronym
RI-B-2021-7300-07
Enrollment
60
Registered
2024-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic idiopathic ano-perineal pain

Brief summary

Comparison between the two treatment arms (lidocaine versus saline) of the rate of patients with a reduction of at least 3 points on a visual analog pain scale (VAS) between inclusion and 1 month after the first injection.

Detailed description

Maintenance of positive response at 3 months, defined as a reduction of at least 3 VAS pain score points (compared with inclusion) 3 months after infiltration., Percentage of patients with a VAS score equal to 0 at 1 month after the first infiltration, Delta of the score on question 9 of the "modified" Concise Pain Questionnaire (CPQ) (French version of the Brief Pain Inventory) concerning the impact of pain, Delta of scores A (anxiety dimension) and D (depression dimension) on the HAD scale, Delta of the score for part A of the French version of the CSI central sensitization score

Interventions

DRUGLIDOCAINE AGUETTANT 10 mg/mL SANS CONSERVATEUR
DRUGSolution injectable
DRUG9 %
DRUGsolution injectable

Sponsors

Groupe Hospitalier Diaconesses Croix Saint Simon
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Comparison between the two treatment arms (lidocaine versus saline) of the rate of patients with a reduction of at least 3 points on a visual analog pain scale (VAS) between inclusion and 1 month after the first injection.

Secondary

MeasureTime frame
Maintenance of positive response at 3 months, defined as a reduction of at least 3 VAS pain score points (compared with inclusion) 3 months after infiltration., Percentage of patients with a VAS score equal to 0 at 1 month after the first infiltration, Delta of the score on question 9 of the "modified" Concise Pain Questionnaire (CPQ) (French version of the Brief Pain Inventory) concerning the impact of pain, Delta of scores A (anxiety dimension) and D (depression dimension) on the HAD scale, Delta of the score for part A of the French version of the CSI central sensitization score

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026